D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

EVFM holding history

Evofem Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EVFM overview All 13F holders of EVFM Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 5; Since Q1 2021

Holdings of EVFM by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−491,726−100.0%	Sold out	Holders
Q1 2022	491,726	$167.0K	<0.1%	−1,768,200−78.2%	Reduced	Holders
Q4 2021	2,259,926	$848.0K	<0.1%	−2,242,397−49.8%	Reduced	Holders
Q3 2021	4,502,323	$3.33M	<0.1%	−36,205−0.8%	Reduced	Holders
Q2 2021	4,538,528	$5.13M	<0.1%	+3,817,760+529.7%	Added	Holders
Q1 2021	720,768	$1.26M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.